186 related articles for article (PubMed ID: 38144556)
41. Evidence of SARS-CoV-2 infection in postmortem lung, kidney, and liver samples, revealing cellular targets involved in COVID-19 pathogenesis.
Falcón-Cama V; Montero-González T; Acosta-Medina EF; Guillen-Nieto G; Berlanga-Acosta J; Fernández-Ortega C; Alfonso-Falcón A; Gilva-Rodríguez N; López-Nocedo L; Cremata-García D; Matos-Terrero M; Pentón-Rol G; Valdés I; Oramas-Díaz L; Suarez-Batista A; Noa-Romero E; Cruz-Sui O; Sánchez D; Borrego-Díaz AI; Valdés-Carreras JE; Vizcaino A; Suárez-Alba J; Valdés-Véliz R; Bergado G; González MA; Hernandez T; Alvarez-Arzola R; Ramírez-Suárez AC; Casillas-Casanova D; Lemos-Pérez G; Blanco-Águila OR; Díaz A; González Y; Bequet-Romero M; Marín-Prida J; Hernández-Perera JC; Del Rosario-Cruz L; Marin-Díaz AP; González-Bravo M; Borrajero I; Acosta-Rivero N
Arch Virol; 2023 Feb; 168(3):96. PubMed ID: 36842152
[TBL] [Abstract][Full Text] [Related]
42. Platelets and renal failure in the SARS-CoV-2 syndrome.
Taha M; Sano D; Hanoudi S; Esber Z; Elahi M; Gabali A; Chopra T; Draghici S; Samavati L
Platelets; 2021 Jan; 32(1):130-137. PubMed ID: 32892687
[TBL] [Abstract][Full Text] [Related]
43. COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection.
Beyerstedt S; Casaro EB; Rangel ÉB
Eur J Clin Microbiol Infect Dis; 2021 May; 40(5):905-919. PubMed ID: 33389262
[TBL] [Abstract][Full Text] [Related]
44. Host-Virus Chimeric Events in SARS-CoV-2-Infected Cells Are Infrequent and Artifactual.
Yan B; Chakravorty S; Mirabelli C; Wang L; Trujillo-Ochoa JL; Chauss D; Kumar D; Lionakis MS; Olson MR; Wobus CE; Afzali B; Kazemian M
J Virol; 2021 Jul; 95(15):e0029421. PubMed ID: 33980601
[TBL] [Abstract][Full Text] [Related]
45. SARS-CoV-2 Spike Protein Destabilizes Microvascular Homeostasis.
Panigrahi S; Goswami T; Ferrari B; Antonelli CJ; Bazdar DA; Gilmore H; Freeman ML; Lederman MM; Sieg SF
Microbiol Spectr; 2021 Dec; 9(3):e0073521. PubMed ID: 34935423
[TBL] [Abstract][Full Text] [Related]
46. SARS-CoV-2 infection impairs the insulin/IGF signaling pathway in the lung, liver, adipose tissue, and pancreatic cells via IRF1.
Shin J; Toyoda S; Nishitani S; Onodera T; Fukuda S; Kita S; Fukuhara A; Shimomura I
Metabolism; 2022 Aug; 133():155236. PubMed ID: 35688210
[TBL] [Abstract][Full Text] [Related]
47. An improved Fuzzy based GWO algorithm for predicting the potential host receptor of COVID-19 infection.
Achom A; Das R; Pakray P
Comput Biol Med; 2022 Dec; 151(Pt A):106050. PubMed ID: 36334362
[TBL] [Abstract][Full Text] [Related]
48. SARS-CoV-2 Infects Endothelial Cells
Liu F; Han K; Blair R; Kenst K; Qin Z; Upcin B; Wörsdörfer P; Midkiff CC; Mudd J; Belyaeva E; Milligan NS; Rorison TD; Wagner N; Bodem J; Dölken L; Aktas BH; Vander Heide RS; Yin XM; Kolls JK; Roy CJ; Rappaport J; Ergün S; Qin X
Front Cell Infect Microbiol; 2021; 11():701278. PubMed ID: 34307198
[TBL] [Abstract][Full Text] [Related]
49. TGF-β1 Inhibition of ACE2 Mediated by miRNA Uncovers Novel Mechanism of SARS-CoV-2 Pathogenesis.
Hejenkowska ED; Mitash N; Donovan JE; Chandra A; Bertrand C; De Santi C; Greene CM; Mu F; Swiatecka-Urban A
J Innate Immun; 2023; 15(1):629-646. PubMed ID: 37579743
[TBL] [Abstract][Full Text] [Related]
50. Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome.
van de Veerdonk FL; Netea MG; van Deuren M; van der Meer JW; de Mast Q; Brüggemann RJ; van der Hoeven H
Elife; 2020 Apr; 9():. PubMed ID: 32338605
[TBL] [Abstract][Full Text] [Related]
51. COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets.
Delorey TM; Ziegler CGK; Heimberg G; Normand R; Yang Y; Segerstolpe Å; Abbondanza D; Fleming SJ; Subramanian A; Montoro DT; Jagadeesh KA; Dey KK; Sen P; Slyper M; Pita-Juárez YH; Phillips D; Biermann J; Bloom-Ackermann Z; Barkas N; Ganna A; Gomez J; Melms JC; Katsyv I; Normandin E; Naderi P; Popov YV; Raju SS; Niezen S; Tsai LT; Siddle KJ; Sud M; Tran VM; Vellarikkal SK; Wang Y; Amir-Zilberstein L; Atri DS; Beechem J; Brook OR; Chen J; Divakar P; Dorceus P; Engreitz JM; Essene A; Fitzgerald DM; Fropf R; Gazal S; Gould J; Grzyb J; Harvey T; Hecht J; Hether T; Jané-Valbuena J; Leney-Greene M; Ma H; McCabe C; McLoughlin DE; Miller EM; Muus C; Niemi M; Padera R; Pan L; Pant D; Pe'er C; Pfiffner-Borges J; Pinto CJ; Plaisted J; Reeves J; Ross M; Rudy M; Rueckert EH; Siciliano M; Sturm A; Todres E; Waghray A; Warren S; Zhang S; Zollinger DR; Cosimi L; Gupta RM; Hacohen N; Hibshoosh H; Hide W; Price AL; Rajagopal J; Tata PR; Riedel S; Szabo G; Tickle TL; Ellinor PT; Hung D; Sabeti PC; Novak R; Rogers R; Ingber DE; Jiang ZG; Juric D; Babadi M; Farhi SL; Izar B; Stone JR; Vlachos IS; Solomon IH; Ashenberg O; Porter CBM; Li B; Shalek AK; Villani AC; Rozenblatt-Rosen O; Regev A
Nature; 2021 Jul; 595(7865):107-113. PubMed ID: 33915569
[TBL] [Abstract][Full Text] [Related]
52. Role of pirfenidone in TGF-β pathways and other inflammatory pathways in acute respiratory syndrome coronavirus 2 (SARS-Cov-2) infection: a theoretical perspective.
Hamidi SH; Kadamboor Veethil S; Hamidi SH
Pharmacol Rep; 2021 Jun; 73(3):712-727. PubMed ID: 33880743
[TBL] [Abstract][Full Text] [Related]
53. Investigation of COVID-19 comorbidities reveals genes and pathways coincident with the SARS-CoV-2 viral disease.
Dolan ME; Hill DP; Mukherjee G; McAndrews MS; Chesler EJ; Blake JA
Sci Rep; 2020 Nov; 10(1):20848. PubMed ID: 33257774
[TBL] [Abstract][Full Text] [Related]
54. Downregulation of microRNA-146a in diabetes, obesity and hypertension may contribute to severe COVID-19.
Roganović J
Med Hypotheses; 2021 Jan; 146():110448. PubMed ID: 33338955
[TBL] [Abstract][Full Text] [Related]
55. SARS-CoV-2 spike protein-mediated cell signaling in lung vascular cells.
Suzuki YJ; Nikolaienko SI; Dibrova VA; Dibrova YV; Vasylyk VM; Novikov MY; Shults NV; Gychka SG
Vascul Pharmacol; 2021 Apr; 137():106823. PubMed ID: 33232769
[TBL] [Abstract][Full Text] [Related]
56. Clinical analysis and pluripotent stem cells-based model reveal possible impacts of ACE2 and lung progenitor cells on infants vulnerable to COVID-19.
Zhang Z; Guo L; Lu X; Zhang C; Huang L; Wang X; Duan F; Liang H; Chen P; Zeng L; Shao J; Li H; Li L; Liu L; Li C; Zhang J; Ma CY; Kwan KY; Liu W; Xu Y; Gu X; Jiang H; Du H; Zhang T; Wu Y; Yu G; Chen J; Luo R; Liao C; Tse HF; Chen Z; Chen HJ; Xia H; Lian Q
Theranostics; 2021; 11(5):2170-2181. PubMed ID: 33500718
[No Abstract] [Full Text] [Related]
57. GPR183 antagonism reduces macrophage infiltration in influenza and SARS-CoV-2 infection.
Foo CX; Bartlett S; Chew KY; Ngo MD; Bielefeldt-Ohmann H; Arachchige BJ; Matthews B; Reed S; Wang R; Smith C; Sweet MJ; Burr L; Bisht K; Shatunova S; Sinclair JE; Parry R; Yang Y; Lévesque JP; Khromykh A; Rosenkilde MM; Short KR; Ronacher K
Eur Respir J; 2023 Mar; 61(3):. PubMed ID: 36396144
[TBL] [Abstract][Full Text] [Related]
58. Local Complement Contributes to Pathogenic Activation of Lung Endothelial Cells in SARS-CoV-2 Infection.
Zhang H; Gerasimovskaya E; McCarthy MK; May NA; Prasad RR; Riddle S; McKeon BA; Kumar S; Li M; Hu CJ; Frid MG; Morrison TE; Stenmark KR
Am J Respir Cell Mol Biol; 2023 Aug; 69(2):210-219. PubMed ID: 37071849
[TBL] [Abstract][Full Text] [Related]
59. Syrian hamsters as a model of lung injury with SARS-CoV-2 infection: Pathologic, physiologic, and detailed molecular profiling.
Bednash JS; Kagan VE; Englert JA; Farkas D; Tyurina YY; Tyurin VA; Samovich SN; Farkas L; Elhance A; Johns F; Lee H; Cheng L; Majumdar A; Jones D; Mejia OR; Ruane-Foster M; Londino JD; Mallampalli RK; Robinson RT
Transl Res; 2022 Feb; 240():1-16. PubMed ID: 34740873
[TBL] [Abstract][Full Text] [Related]
60. Issues of Cardiovascular Risk Management in People With Diabetes in the COVID-19 Era.
Ceriello A; Standl E; Catrinoiu D; Itzhak B; Lalic NM; Rahelic D; Schnell O; Škrha J; Valensi P;
Diabetes Care; 2020 Jul; 43(7):1427-1432. PubMed ID: 32409501
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
